Copyright: ©Author(s) 2026.
World J Cardiol. Mar 26, 2026; 18(3): 112189
Published online Mar 26, 2026. doi: 10.4330/wjc.v18.i3.112189
Published online Mar 26, 2026. doi: 10.4330/wjc.v18.i3.112189
Figure 2 Primary endpoints.
A: Weight reduction; B: Adjudicated heart failure event.
- Citation: Mylavarapu M, Obi O, Abarca Y, Fatima H, Roshni P, Huda NU, Lysak Y, Gandapur A, Vazquez SC, Siddiqui MA, Mowo-Wale A. Semaglutide in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta-analysis. World J Cardiol 2026; 18(3): 112189
- URL: https://www.wjgnet.com/1949-8462/full/v18/i3/112189.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i3.112189